Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rochlitz

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
British Journal of Haematology|November 1, 1993
Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukaemiaA Neubauer, E de Kant, C Rochlitz, et al.
Psycho-Oncology|April 16, 2018
Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed-methods studyT Tondorf, A Grossert, S I Rothschild, et al.
Oncology|April 22, 2008
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)D Hess, D Koberle, B Thurlimann, et al.
European Journal of Immunology|September 29, 2000
Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell responseA Donda, L Mori, A Shamshiev, et al.
Genes, Chromosomes & Cancer|June 8, 2001
Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7J L Boulay, G Mild, J Reuter, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
British Journal of Cancer|April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialR Morant, J Bernhard, D Dietrich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2013
Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumoursA Romer, D Seiler, N Marincek, et al.
Human Gene Therapy|October 6, 1998
A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancerM Schuler, C Rochlitz, J A Horowitz, et al.
British Journal of Cancer|November 15, 2000
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
British Journal of Haematology|November 1, 1993
Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukaemiaA Neubauer, E de Kant, C Rochlitz, et al.
Psycho-Oncology|April 16, 2018
Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed-methods studyT Tondorf, A Grossert, S I Rothschild, et al.
Oncology|April 22, 2008
Capecitabine and vinorelbine as first-line treatment in elderly patients (> or =65 years) with metastatic breast cancer. A phase II trial (SAKK 25/99)D Hess, D Koberle, B Thurlimann, et al.
European Journal of Immunology|September 29, 2000
Locally inducible CD66a (CEACAM1) as an amplifier of the human intestinal T cell responseA Donda, L Mori, A Shamshiev, et al.
Genes, Chromosomes & Cancer|June 8, 2001
Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7J L Boulay, G Mild, J Reuter, et al.
Cancer Gene Therapy|June 8, 1999
Gene therapy study of cytokine-transfected xenogeneic cells (Vero-interleukin-2) in patients with metastatic solid tumorsC Rochlitz, P Jantscheff, G Bongartz, et al.
British Journal of Cancer|April 1, 2004
Capecitabine in hormone-resistant metastatic prostatic carcinoma - a phase II trialR Morant, J Bernhard, D Dietrich, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2013
Somatostatin-based radiopeptide therapy with [177Lu-DOTA]-TOC versus [90Y-DOTA]-TOC in neuroendocrine tumoursA Romer, D Seiler, N Marincek, et al.
Human Gene Therapy|October 6, 1998
A phase I study of adenovirus-mediated wild-type p53 gene transfer in patients with advanced non-small cell lung cancerM Schuler, C Rochlitz, J A Horowitz, et al.
British Journal of Cancer|November 15, 2000
Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findingsE Tartour, M Mehtali, X Sastre-Garau, et al.
Pageof 5